Katia Scotlandi
Overview
Explore the profile of Katia Scotlandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
3690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landuzzi L, Ruzzi F, Lollini P, Scotlandi K
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40004005
Chondrosarcoma (CS), the second most common malignant bone tumor after osteosarcoma, accounts for 20-30% of all malignant bone tumors. It mainly affects adults, middle-aged, and elderly people. The CS family...
2.
Ferrari C, Magagnoli G, Laranga R, Bianchi G, Carretta E, Cesari M, et al.
Diagnostics (Basel)
. 2025 Feb;
15(3).
PMID: 39941258
: Musculoskeletal neoplasms are rare and challenging diseases. Their geographic pattern varies worldwide, and no studies analyze their distribution in Italy. The aim of this study was to investigate a...
3.
Kasan M, Geyer F, Siebenlist J, Sill M, Ollinger R, Faehling T, et al.
Nat Commun
. 2025 Jan;
16(1):380.
PMID: 39753532
Human cancer cell lines are the mainstay of cancer research. Recent reports showed that highly mutated adult carcinoma cell lines (mainly HeLa and MCF-7) present striking diversity across laboratories and...
4.
Toracchio L, Carrabotta M, Mancarella C, Morrione A, Scotlandi K
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596256
Erythropoietin-producing hepatocellular A2 (EphA2) is a member of the Eph tyrosine kinase receptor family that has been linked to various biological processes. In tumors, EphA2 overexpression is associated with noncanonical...
5.
Pasello M, Laginestra M, Manara M, Landuzzi L, Ruzzi F, Maioli M, et al.
J Cell Commun Signal
. 2024 Nov;
18(3):e12047.
PMID: 39524141
Ewing sarcoma (EwS), a highly aggressive malignancy affecting children and young adults, is primarily driven by a distinctive oncogenic fusion, the EWSR1-ETS, whose activity is a key source of epigenetic...
6.
Maqueda J, De Feo A, Scotlandi K
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456239
Pediatric sarcomas present a significant challenge in oncology. There is an urgent need for improved therapeutic strategies for high-risk patients and better management of long-term side effects for those who...
7.
Salucci S, Bavelloni A, Versari I, Burattini S, Bavelloni F, Gobbi P, et al.
Biomolecules
. 2024 Sep;
14(9).
PMID: 39334946
Rhabdomyosarcoma (RMS), the most common form of sarcoma typical of pediatric age, arises from the malignant transformation of the mesenchymal precursors that fail to differentiate into skeletal muscle cells. Here,...
8.
Mancarella C, Scotlandi K
J Clin Oncol
. 2024 Sep;
42(31):3735-3738.
PMID: 39259926
No abstract available.
9.
Bianchi G, Laginestra M, Simonetti E, Ibrahim T, Macri F, Ostetto F, et al.
Oncol Res Treat
. 2024 Jul;
47(10):496-508.
PMID: 39084202
Introduction: Extraskeletal Ewing sarcoma (EEwS) is a rare malignant tumor, and current international recommendations indicate systemic and local treatment like bone Ewing sarcoma (BEwS); to the best of our knowledge,...
10.
Cristalli C, Scotlandi K
Cells
. 2024 Jul;
13(14.
PMID: 39056791
DNA methylation is a key epigenetic regulatory mechanism that plays a critical role in a variety of cellular processes, including the regulation of cell fate during development, maintenance of cell...